Chugai Pharmaceutical Co Ltd
TSE:4519

Watchlist Manager
Chugai Pharmaceutical Co Ltd Logo
Chugai Pharmaceutical Co Ltd
TSE:4519
Watchlist
Price: 7 130 JPY 0.01% Market Closed
Market Cap: 11.7T JPY
Have any thoughts about
Chugai Pharmaceutical Co Ltd?
Write Note

Chugai Pharmaceutical Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chugai Pharmaceutical Co Ltd
Operating Income Peer Comparison

Comparables:
4502
4568
4578
S
4507
4503

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Chugai Pharmaceutical Co Ltd
TSE:4519
Operating Income
ÂĄ540.2B
CAGR 3-Years
15%
CAGR 5-Years
24%
CAGR 10-Years
21%
Takeda Pharmaceutical Co Ltd
TSE:4502
Operating Income
ÂĄ403B
CAGR 3-Years
-17%
CAGR 5-Years
13%
CAGR 10-Years
12%
Daiichi Sankyo Co Ltd
TSE:4568
Operating Income
ÂĄ260.5B
CAGR 3-Years
51%
CAGR 5-Years
19%
CAGR 10-Years
7%
Otsuka Holdings Co Ltd
TSE:4578
Operating Income
ÂĄ353.6B
CAGR 3-Years
19%
CAGR 5-Years
33%
CAGR 10-Years
5%
S
Shionogi & Co Ltd
TSE:4507
Operating Income
ÂĄ134.8B
CAGR 3-Years
7%
CAGR 5-Years
-11%
CAGR 10-Years
10%
Astellas Pharma Inc
TSE:4503
Operating Income
ÂĄ130.6B
CAGR 3-Years
-1%
CAGR 5-Years
-13%
CAGR 10-Years
-1%

See Also

What is Chugai Pharmaceutical Co Ltd's Operating Income?
Operating Income
540.2B JPY

Based on the financial report for Sep 30, 2024, Chugai Pharmaceutical Co Ltd's Operating Income amounts to 540.2B JPY.

What is Chugai Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
21%

Over the last year, the Operating Income growth was 14%. The average annual Operating Income growth rates for Chugai Pharmaceutical Co Ltd have been 15% over the past three years , 24% over the past five years , and 21% over the past ten years .

Back to Top